메뉴 건너뛰기




Volumn 15, Issue 2, 1997, Pages 735-743

Paclitaxel by 96-hour continuous infusion in combination with cisplatin: A phase I trial in patients with advanced lung cancer

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

EID: 0031029848     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.735     Document Type: Article
Times cited : (25)

References (32)
  • 1
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
    • Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899-909, 1995
    • (1995) BMJ , vol.311 , pp. 899-909
  • 2
    • 0026440636 scopus 로고
    • Drug therapy: Chemotherapy of lung cancer
    • Ihde DC: Drug therapy: Chemotherapy of lung cancer. N Engl J Med 327:1434-1441, 1992
    • (1992) N Engl J Med , vol.327 , pp. 1434-1441
    • Ihde, D.C.1
  • 3
    • 84994521433 scopus 로고
    • Drug therapy: Paclitaxel (Taxol)
    • Rowinsky EK, Donehower RC: Drug therapy: Paclitaxel (Taxol). N Engl J Med 332:1004-1014, 1995
    • (1995) N Engl J Med , vol.332 , pp. 1004-1014
    • Rowinsky, E.K.1    Donehower, R.C.2
  • 4
    • 0027412646 scopus 로고
    • Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer
    • Murphy WK, Fossella FV, Winn RJ, et al.: Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85:384-388, 1993
    • (1993) J Natl Cancer Inst , vol.85 , pp. 384-388
    • Murphy, W.K.1    Fossella, F.V.2    Winn, R.J.3
  • 5
    • 0027537911 scopus 로고
    • Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results
    • Chang AY, Kim K, Glick J, et al.: Phase II study of Taxol, merbarone, and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85:388-394, 1993
    • (1993) J Natl Cancer Inst , vol.85 , pp. 388-394
    • Chang, A.Y.1    Kim, K.2    Glick, J.3
  • 6
    • 0029003733 scopus 로고
    • Paclitaxel by 1-hour infusion: An active drug in metastatic non-small-cell lung cancer
    • Hainsworth JD, Thompson DS, Greco FA: Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer. J Clin Oncol 13:1609-1614, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 1609-1614
    • Hainsworth, J.D.1    Thompson, D.S.2    Greco, F.A.3
  • 7
    • 9044222488 scopus 로고    scopus 로고
    • Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer
    • Millward MJ, Bishop JF, Friedlander M, et al.: Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol 14:142-148, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 142-148
    • Millward, M.J.1    Bishop, J.F.2    Friedlander, M.3
  • 8
    • 0029071979 scopus 로고
    • Phase II study of paclitaxel in patients with extensive-stage small cell lung cancer: An Eastern Cooperative Oncology Group study
    • Ettinger DS, Finkelstein DM, Sarma RP, et al.: Phase II study of paclitaxel in patients with extensive-stage small cell lung cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 13:1430-1435, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 1430-1435
    • Ettinger, D.S.1    Finkelstein, D.M.2    Sarma, R.P.3
  • 9
    • 0028175116 scopus 로고
    • The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines
    • Liebmann J, Cook JA, Lipschultz C, et al.: The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines. Cancer Chemother Pharmacol 33:331-339, 1994
    • (1994) Cancer Chemother Pharmacol , vol.33 , pp. 331-339
    • Liebmann, J.1    Cook, J.A.2    Lipschultz, C.3
  • 10
    • 0029050938 scopus 로고
    • Four-day paclitaxel infusion with cisplatin for patients with lung cancer
    • Georgiadis MS, Schuler B, Johnson BE: Four-day paclitaxel infusion with cisplatin for patients with lung cancer. Semin Oncol 22:67-69, 1995
    • (1995) Semin Oncol , vol.22 , pp. 67-69
    • Georgiadis, M.S.1    Schuler, B.2    Johnson, B.E.3
  • 11
    • 0028110931 scopus 로고
    • Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: A phase I/ II trial of 96-hour infusion
    • Wilson WH, Berg SL, Bryant G, et al.: Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: A phase I/ II trial of 96-hour infusion. J Clin Oncol 12:1621-1629, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 1621-1629
    • Wilson, W.H.1    Berg, S.L.2    Bryant, G.3
  • 12
    • 0028817461 scopus 로고
    • Phase II study of paclitaxel in relapsed non-Hodgkin's lymphoma
    • Wilson WH, Chabner BA, Bryant G, et al.: Phase II study of paclitaxel in relapsed non-Hodgkin's lymphoma. J Clin Oncol 13:381-386, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 381-386
    • Wilson, W.H.1    Chabner, B.A.2    Bryant, G.3
  • 13
    • 0025850566 scopus 로고
    • Sequences of Taxol and cisplatin: A phase I and pharmacologic study
    • Rowinsky EK, Gilbert MR, McGuire WP, et al.: Sequences of Taxol and cisplatin: A phase I and pharmacologic study. J Clin Oncol 9:1692-1703, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 1692-1703
    • Rowinsky, E.K.1    Gilbert, M.R.2    McGuire, W.P.3
  • 14
    • 0001770154 scopus 로고
    • Appendix A: Grading of Toxicity
    • Philadelphia, PA, Lippincott
    • Wittes RE: Appendix A: Grading of Toxicity, in Manual of Oncologic Therapeutics 1989/1990. Philadelphia, PA, Lippincott, 1989, pp 445-448
    • (1989) Manual of Oncologic Therapeutics 1989/1990 , pp. 445-448
    • Wittes, R.E.1
  • 15
    • 12044258548 scopus 로고
    • Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing
    • Shaw GL, Gazdar AF, Phelps R, et al.: Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187, 1993
    • (1993) Cancer Res , vol.53 , pp. 5181-5187
    • Shaw, G.L.1    Gazdar, A.F.2    Phelps, R.3
  • 16
    • 0028149937 scopus 로고
    • Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
    • Ihde DC, Mulshine JL, Kramer BS, et al.: Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 12:2022-2034, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 2022-2034
    • Ihde, D.C.1    Mulshine, J.L.2    Kramer, B.S.3
  • 17
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.1    Meier, P.2
  • 18
    • 0027504607 scopus 로고
    • 2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer
    • 2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer. Cancer Chemother Pharmacol 33:48-52, 1993
    • (1993) Cancer Chemother Pharmacol , vol.33 , pp. 48-52
    • Jamis-Dow, C.A.1    Klecker, R.W.2    Saosy, G.3
  • 19
    • 0028154069 scopus 로고
    • Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
    • Le Chevalier T, Brisgand D, Douillard JY, et al.: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 360-367
    • Le Chevalier, T.1    Brisgand, D.2    Douillard, J.Y.3
  • 20
    • 0029098178 scopus 로고
    • Paclitaxel and carboplatin in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis
    • Langer CJ, Leighton JC, Comis RL, et al.: Paclitaxel and carboplatin in the treatment of advanced non-small-cell lung cancer: A phase II toxicity, response, and survival analysis. J Clin Oncol 13:1860-1870, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 1860-1870
    • Langer, C.J.1    Leighton, J.C.2    Comis, R.L.3
  • 21
    • 0000719909 scopus 로고    scopus 로고
    • Phase III trial comparing etoposide-cisplatin versus Taxol with cisplatin-G-CSF versus Taxol-cisplatin in advanced non-small cell lung cancer
    • An Eastern Cooperative Oncology Group trial. abstr 1145
    • Bonomi P, Kim K, Chang A, et al.: Phase III trial comparing etoposide-cisplatin versus Taxol with cisplatin-G-CSF versus Taxol-cisplatin in advanced non-small cell lung cancer. An Eastern Cooperative Oncology Group trial. Proc Am Soc Clin Oncol 15:382, 1996 (abstr 1145)
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 382
    • Bonomi, P.1    Kim, K.2    Chang, A.3
  • 22
    • 0029148461 scopus 로고
    • Phase II trial of paclitaxel by 3-hour infusion as initial and salvage therapy for metastatic breast cancer
    • Seidman AD, Tiersten A, Hudis C, et al.: Phase II trial of paclitaxel by 3-hour infusion as initial and salvage therapy for metastatic breast cancer. J Clin Oncol 13:2575-2581, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 2575-2581
    • Seidman, A.D.1    Tiersten, A.2    Hudis, C.3
  • 23
    • 0029946928 scopus 로고    scopus 로고
    • Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer
    • Seidman AD, Hochhauser D, Gollub M, et al.: Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: A phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. J Clin Oncol 14:1877-1884, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 1877-1884
    • Seidman, A.D.1    Hochhauser, D.2    Gollub, M.3
  • 24
    • 0023254952 scopus 로고
    • In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy
    • Wolff SN, Grosh WW, Prater K, et al.: In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy. Cancer Chemother Pharmacol 19:246-249, 1987
    • (1987) Cancer Chemother Pharmacol , vol.19 , pp. 246-249
    • Wolff, S.N.1    Grosh, W.W.2    Prater, K.3
  • 25
    • 0024417601 scopus 로고
    • A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer
    • Slevin ML, Clark PI, Joel SP, et al.: A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol 7:1333-1340, 1989
    • (1989) J Clin Oncol , vol.7 , pp. 1333-1340
    • Slevin, M.L.1    Clark, P.I.2    Joel, S.P.3
  • 26
    • 0027360291 scopus 로고
    • Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose-limiting
    • Rowinsky EK, Chaudhry V, Forastiere AA, et al.: Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose-limiting. J Clin Oncol 11:2010-2020, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 2010-2020
    • Rowinsky, E.K.1    Chaudhry, V.2    Forastiere, A.A.3
  • 27
    • 0027999966 scopus 로고
    • European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion
    • Eisenhauer EA, Huinink WW, Swenerton KD, et al.: European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: High-dose versus low-dose and long versus short infusion. J Clin Oncol 12:2654-2666, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 2654-2666
    • Eisenhauer, E.A.1    Huinink, W.W.2    Swenerton, K.D.3
  • 28
    • 0027093094 scopus 로고
    • Taxol administered as a 120 hour infusion
    • Spriggs DR, Tondini C: Taxol administered as a 120 hour infusion. Invest New Drugs 10:275-278, 1992
    • (1992) Invest New Drugs , vol.10 , pp. 275-278
    • Spriggs, D.R.1    Tondini, C.2
  • 29
    • 0018591945 scopus 로고
    • Toxic effects of cis-dichlorodiammineplatinum(II) in man
    • Von Hoff DD, Schilsky R, Reichert CM, et al.: Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63:1527-1531, 1979
    • (1979) Cancer Treat Rep , vol.63 , pp. 1527-1531
    • Von Hoff, D.D.1    Schilsky, R.2    Reichert, C.M.3
  • 30
    • 0022461326 scopus 로고
    • Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer
    • Kris MG, Gralla RJ, Wertheim MS, et al.: Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rep 70:1091-1096, 1986
    • (1986) Cancer Treat Rep , vol.70 , pp. 1091-1096
    • Kris, M.G.1    Gralla, R.J.2    Wertheim, M.S.3
  • 31
    • 0021850136 scopus 로고
    • Unresectable non-small cell lung cancer chemotherapy with high-dose cisplatin and etoposide
    • Scagliotti GV, Lodico D, Gozzelino F, et al.: Unresectable non-small cell lung cancer chemotherapy with high-dose cisplatin and etoposide. Oncology 42:224-228, 1985
    • (1985) Oncology , vol.42 , pp. 224-228
    • Scagliotti, G.V.1    Lodico, D.2    Gozzelino, F.3
  • 32
    • 0019492001 scopus 로고
    • Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules
    • Gralla RJ, Casper ES, Kelson DP, et al.: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern Med 95:414-420, 1981
    • (1981) Ann Intern Med , vol.95 , pp. 414-420
    • Gralla, R.J.1    Casper, E.S.2    Kelson, D.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.